Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant type I CRISPR-Cas system and uses thereof for genome modification and alteration of expression

Recombinant type I CRISPR-Cas system and uses thereof for genome modification and alteration of expression

US Patent 12264313 · Granted Apr 1, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genome engineering with CRISPR-Cas systems in eukaryotes2025
RNA-guided nucleases and active fragments and variants thereof and methods of us2025
Recombinant type I CRISPR-Cas system and uses thereof for killing target cells2025
Recombinant type I CRISPR-Cas system and uses thereof for killing target cells2025
Recombinant type I CRISPR-Cas system and uses thereof for screening for variant 2025
Recombinant type I CRISPR-Cas system and uses thereof for screening for variant 2025
RNA-guided nucleases and active fragments and variants thereof and methods of us2024
Cas9 proteins and guiding features for DNA targeting and genome editing2023
Recombinant type I CRISPR-CAS system2023
Methods and compositions for delivery of CRISPR based antimicrobials2023
Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus2022
Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic a2022